Showing results (21-30 of 327) with videos related to
Sort By:
Pageof 33
World Journal of Gastroenterology|July 1, 2014
Pancreatic biomarkers: could they be the answer?Angela Lamarca, Jaime FeliuJournal of Hepatology|November 18, 2022
Integrating cytotoxic, targeted and immune therapies for cholangiocarcinomaJoachim Merters, Angela LamarcaAnnales De Pathologie|December 17, 2011
[The pathologist's role in the neoadjuvant strategy of renal-cell carcinoma]Xavier Leroy, Julien Edeline, Nathalie Rioux-LeclercqExpert Review of Gastroenterology & Hepatology|November 25, 2016
Development of sorafenib-related side effects in patients diagnosed with advanced hepatocellular carcinoma treated with sorafenib: a systematic-review and meta-analysis of the impact on survivalOmar Abdel-Rahman, Angela LamarcaEuropean Journal of Nuclear Medicine and Molecular Imaging|September 5, 2015
Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheresEtienne Garin, Yan Rolland, Sophie Laffont, et al.Journal of Hematology & Oncology|April 20, 2021
CAR-T cells and BiTEs in solid tumors: challenges and perspectivesJulien Edeline, Roch Houot, Aurélien Marabelle, et al.Endocrine-Related Cancer|July 15, 2016
Ki-67 index and response to chemotherapy in patients with neuroendocrine tumoursAlexa Childs, Amy Kirkwood, Julien Edeline, et al.Cancer Treatment Reviews|December 25, 2012
Thymoma and thymic carcinoma in the target therapies eraAngela Lamarca, Victor Moreno, Jaime FeliuCritical Reviews in Oncology/Hematology|July 4, 2016
Hepatocellular carcinoma: Exploring the impact of ethnicity on molecular biologyAngela Lamarca, Marta Mendiola, Jorge BarriusoCancer Treatment Reviews|July 19, 2024
Comparative analysis of international guidelines on the management of advanced non-functioning well-differentiated pancreatic neuroendocrine tumorsFrancesco Panzuto, Angela Lamarca, Nicola FazioPageof 33